Related Experiment Video
Updated: Apr 16, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Postmortem Findings and Clinical Correlates in Individuals with Infantile-Onset Pompe Disease
Loren D M Pena1, Alan D Proia, Priya S Kishnani
1Division of Medical Genetics, Department of Pediatrics, Duke Medicine, 905 S. LaSalle St., GSRB1, Box 103856, Durham, NC, 27710, USA, loren.pena@duke.edu.
Abstract:
Pompe disease (OMIM 232300), a glycogen storage disorder caused by deficiency in the lysosomal enzyme acid alpha-glucosidase (EC 3.2.1.20), results in weakness and cardiomyopathy in infants affected with the classic form. Although the primary disease manifestations are due to glycogen accumulation in skeletal and cardiac muscle, glycogen also accumulates in a variety of additional tissues. To improve our understanding of disease pathogenesis in long-term survivors, we reviewed postmortem results for three infants with the classic form of Pompe disease. We have observed a number of new complications in long-term survivors of infantile-onset Pompe disease, and we focused this postmortem study on pathological correlates. Findings in survivors include cardiac arrhythmias, which may be related to glycogen accumulation in cardiac conduction tissue; urinary incontinence, likely due to glycogen accumulation in smooth muscle; and refractory errors, possibly related to accumulation in ocular structures. These observations provide potential pathophysiologic correlates for complications in long-term survivors of infantile Pompe disease.
More Related Videos
Related Concept Videos
Lysosomal Hydrolases
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Methods of Documentation II: POMR
Toxidromes: Clinical Features

